Voloridge Investment Management
CCXI

Voloridge Investment Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Voloridge Investment Management’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-362,291
Closed -$8.98M – 1679
2022
Q2 		$8.98M Sell
362,291
-301,944
-45% -$6.66M 0.05% 481
2022
Q1 		$16.7M Buy
664,235
+264,773
+66% +$7.44M 0.09% 289
2021
Q4 		$14.5M Sell
399,462
-187,714
-32% -$6.59M 0.08% 356
2021
Q3 		$10M Sell
587,176
-225,740
-28% -$3.52M 0.06% 435
2021
Q2 		$10.9M Buy
+812,916
New +$20M 0.08% 377

Other funds holding CCXI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Voloridge Investment Management's CCXI Position: Q3 2022 in Review

Voloridge Investment Management sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 362,291 shares — an estimated $8.98M sold.

Voloridge Investment Management first reported a position in CCXI in Q2 2021 and held it in 5 quarters. The position peaked at $16.7M in Q1 2022. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

  • Voloridge Investment Management reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 362,291 ChemoCentryx, Inc. shares in Q3 2022, an estimated $8.98M.
  • Voloridge Investment Management first reported a position in ChemoCentryx, Inc. in Q2 2021 and held it in 5 quarters.
  • Voloridge Investment Management's ChemoCentryx, Inc. position peaked at $16.7M in Q1 2022.
  • 217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on Voloridge Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.